Dr. Phil Hart, MD, AGA Exposing EPI campaign chair, gastroenterologist, The Ohio State University Wexner Medical Center, Columbus discusses new data from the American Gastroenterological Association (AGA) revealing Americans are suffering in silence when it comes to GI symptoms and may not be aware of a serious condition called exocrine pancreatic insufficiency (EPI). The survey comes at a time when digestive diseases account for more than 100 million ambulatory care visits every year in the U.S. (NIH.gov) and uncovered trends around patient and provider dialogue around GI health issues that impact daily activities and could signal a more concerning condition. He encourages seeking early evaluation. Through the Exposing EPI campaign, AGA is educating patients that they don’t have to suffer in silence. Providers and patients looking for more information can visit patient.gastro.org to learn more.
Through the Exposing EPI campaign, AGA is educating patients that they don’t have to suffer in silence. Providers and patients looking for more information, can visit www.patient.gastro.org to learn more.
Phil Hart, MD, is an Associate Professor of Medicine in the Division of Gastroenterology, Hepatology, and Nutrition at The Ohio State University Wexner Medical Center. He completed training at Mayo Clinic in Rochester, Minnesota, including a Medical Pancreatology Fellowship.
Dr. Hart is a councilor for the International Association of Pancreatology and Associate Editor for Pancreatology. He has published extensively regarding the management and long-term outcomes of autoimmune pancreatitis, pancreatogenic diabetes secondary to chronic pancreatitis and pancreatic cancer, and exocrine pancreatic insufficiency. Dr. Hart is an NIH-funded investigator as a multi-PI for both the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer and Type 1 Diabetes after Acute Pancreatitis Consortium (T1DAPC), and is involved in a number of ongoing clinical trials.